| Is this program recognized by ACLAM? | Yes |
| Does this program participate in the Veterinary Internship & Residency Matching Program (VIRMP)? | Yes
|
| Number of concurrent residents | 1
|
| How many residents/trainees have completed this program? | 17
|
| Of these, how many have subsequently become ACLAM Diplomates? | 5
|
| In what year did the program accept its first trainee? |
|
| How many years are required to complete this program (residency only)? | 3
|
| Is formal coursework offered? | Yes |
| Is a degree program associated with this residency? | No
|
| If yes, what degree(s)? |
|
| Which departments most commonly grant degree(s)? |
|
| Give an overview of this program, describing its particular strengths and any unique aspects that are not addressed in any of the other sections | We have a variety of species including a colony of cynomolgus macaque monkeys. The residents are able to get significant clinical experience involving clinical cases, surgical and imaging models. The also learn about drug discovery and requirements for development of drugs including GLP work. They are encouraged to work up cases and required to do a research project. There is a strong welfare component to the program that includes working on projects to improve housing, enrichment and welfare of all species. |
| Describe any unique research interests of your faculty | GSK is a global pharmaceutical company and therefore studies are done in support of discovery and development of drugs. The Laboratory Animal Science department has an imaging group with MRI and PET capability. There are a number of studies that incorporate ultrasound imaging. The site does GLP work the includes General Toxicology and Safety Pharmacology. We have a number of other research areas including oncology, drug metabolism, heart failure, biopharm and infectious diseases. |
| Give a few literature citations of publications completed by trainees during their tenure in this program | Mallon FM, et al. Comparison of antibody response by use of synthetic adjuvant system and Freund complete adjuvant in rabbits. AJVR 52(9):1503-1506 1991
Rock FM, et al. Diagnosis of a case of Mycobacterium tuberculosis in a cynomolgus (Macaca fascicularis) monkey colony by polymerase chain reaction and enzyme-linked immunosorbent assay. LAS 45(3):315-319 1995
Rock FM, et al. Effects of Caging Type and Group Size on Selected Physiologic Variables in Rats. Cont Topics LAS. 36(2):69-72 1997
Schultz LB, et al. Lack of Reactivation of Shigellosis in Naturally Infected Enrofloxacin-Treated Cynomolgus Monkeys After Exogenous Immunosuppression. LAS 47(6):602-605 1997.
Maguire, S., Strittmatter, R., Chandra, S., Barone, F.C. Stroke-prone rats exhibit prolonged behavioral deficits without increased brain injury: an indication of disrupted post-stroke brain recovery of function. Neuroscience Letters, 2004 Jan 16;354(3):229-33.
Yancy AD, et al. Differential uptake of ferumoxtran-10 and ferumoxytol, ultrasmall superparamagnetic iron oxide contrast agents in rabbit: Critical determinants of atherosclerotic plaque labeling. J Magn Reson Imaging 21(4):432-442 2005
Morris JB, et al. Patterns of USPIO Deposition in Murine Atherosclerosis. Arteriosclerosis, Thrombosis, and Vascular Biology. 28(9):158-159. 2008 |
| Where will vacancies be advertised? | Lab animal websites and meetings, CompMed listserv |
| What month does the program begin? | Any |